Guilford, Conn.-based Butterfly Network said in a news release that an integrated solution developed through the partnership should enhance cardiac assessment with the Butterfly iQ+ handheld whole-body ultrasound system that uses the company’s Ultrasound-on-Chip technology.
By leveraging Caption Health’s Caption AI FDA-cleared, AI-guided ultrasound software, the partnership aims to improve the ease of image capture and image interpretation in a number of care settings, including the hospital, clinic and the home.
“Seeing is knowing, and our mission to democratize medical imaging and transform healthcare is enabled by Butterfly’s unique ability to deliver powerful clinical information at the point of care,” Butterfly Network president & CEO Dr. Todd Fruchterman said in the release. “By combining Butterfly’s differentiated solution with Caption’s AI capabilities, we are accelerating on our promise to provide practitioners with an easy-to-use advanced assessment tool that allows them to make more informed clinical decisions earlier in the patient care journey. With this partnership, we are enabling better care that can lead to improved patient outcomes.”
The companies expect to introduce the combined platform on Butterfly IQ+ in the U.S. later this year.
“Our partnership with Butterfly unlocks a new frontier in patient care. This is a pivotal time when imaging can reinvent diagnostic speed and accuracy. Butterfly’s comprehensive and versatile whole-body ultrasound solution will now have FDA-cleared AI guidance and interpretation, allowing every healthcare provider the ability to capture and understand cardiac function, and this is only the beginning,” added Caption Health president & CEO Steve Cashman. “The timing of our recent NTAP approval also means a transparent reimbursement pathway for the millions of Medicare patients receiving in-patient care.”
